REXAHN PHARMACEUTICALS, INC. 4
4 · REXAHN PHARMACEUTICALS, INC. · Filed Jan 14, 2014
Insider Transaction Report
Form 4
Ahn Chang Ho
DirectorChairman & CEO
Transactions
- Award
Stock Option (right to purchase)
2014-01-12+125,000→ 125,000 totalExercise: $1.14Exp: 2024-01-12→ Common Stock (125,000 underlying)
Holdings
- 500,000(indirect: By Spouse)
Common Stock
- 6,813,924
Common Stock
- 250,000
Stock Option (right to purchase)
Exercise: $0.31Exp: 2023-03-01→ Common Stock (250,000 underlying) - 500,000
Stock Option (right to purchase)
Exercise: $0.78Exp: 2018-12-11→ Common Stock (500,000 underlying) - 1,000,000
Stock Option (right to purchase)
Exercise: $0.80Exp: 2015-01-20→ Common Stock (1,000,000 underlying)
Footnotes (5)
- [F1]The reporting person disclaims beneficial ownership of the shares held by his spouse, and this report should not be deemed an admission that the reporting person is the beneficial owner of his spouse's shares for purposes of Section 16 or for any other purpose.
- [F2]Options will vest and be exercisable based on the following schedule: 37,500 on January 12, 2015, 37,500 on January 12, 2016, and 50,000 on January 12, 2017.
- [F3]Options will vest and be exercisable based on the following schedule: 75,000 on March 1, 2014, 75,000 on March 1, 2015, and 100,000 on March 1, 2016.
- [F4]Options vested and became exercisable based on the following schedule 150,000 on December 11, 2009, 150,000 on December 11, 2010, and 200,000 on December 11, 2011.
- [F5]Options vested and became exercisable based on the following schedule 300,000 on January 20, 2006, 300,000 on January 20, 2007, and 400,000 on January 20, 2008.